spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Standardized Syringe Testing with Zwick

ZwickRoell


In today's world, the medical industry is continually faced with the challenge of providing patients with better care. Glass syringes that deliver drugs to patients are an essential part of this care. These glass syringes are typically used in connection with injection needles, needless Luer locks, adapters, and transfer devices.

The need for accurate and repeatable tests on syringes is playing an increasingly important role. Standard ISO 11040-4 provides producers of syringes and drugs a shared basis for producing reliable test results.

Zwick testing solutions to ISO 11040-4

ISO 11040-4 (Prefilled syringes -- Part 4: Glass barrels for injectables and sterilized subassembled syringes ready for filling) defines the following tests:

■C1: Flange breaking resistance
■C2: Luer cone breaking resistance
■E: Glide force test method to evaluate syringe lubrication
■F: Needle penetration test
■G1: Needle pull-out force
■G2: Closure system liquid leakage test
■G3: Luer lock adaptor collar pull-off force
■G4: Luer lock adaptor collar torque resistance
■G5: Luer lock rigid tip cap unscrewing torque
■G6: Pull-off force of the tip cap or the needle shield

Zwick is the first materials testing machine manufacturer that offers a complete portfolio that tests to ISO 11040-4. The interchangeable test fixtures are ideal for various syringe types and ensure that the testing of prefilled syringes is standardized.
phone +49 7305 100
email info@zwick.com
web www.zwick.com/medical
email August-Nagel-Strasse 11, 89079, ULM, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the 11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>


White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

Industry Events

SCOPE Europe Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement